While human clinical trials remain limited, the depth of animal research, consistency of positive findings across multiple study designs, and extensive community experience create a reasonable basis for therapeutic use
How the TB-500 Peptide Works at the Cellular Level: Actin, Angiogenesis, and Migration The primary mechanism of the tb-500 peptide is actin polymerization
GHK-Cu remains one of the more effective non-hormonal options for this group
The reality of oral administration for musculoskeletal indications is straightforward: the peptide disperses through the digestive system before it reaches the injury site, and what arrives at a tendon or joint after that journey is a fraction of what a subcutaneous injection placed near the tissue delivers
Functional medicine can save lives through effective collaborations within health organizations
These findings are somewhat misleading and not all that applicable to human longevity